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INTRODUCTION 
 
Type 2 diabetes and obesity have become major health 
problems that have reached epidemic propor-
tions.  While the exact causes of diabetes are still not 
fully understood, it is known that several factors in-
crease the risk of developing diabetes mellitus. There is 
a close association between obesity and type 2 diabe-
tes. The global epidemic of obesity to a large extent 
explains the dramatic increase in the incidence and 
prevalence of type 2 diabetes over the past two dec-
ades [1]. 
Overweight and obese individuals are at a much higher 
risk of developing type 2 diabetes. In 2014, more than 
1.9 billion adults, 18 years and older, were overweight. 
Of these over 600 million were obese. In 2014 among 
adults aged 18 years and over, 39% were overweight 
and 13% were obese [2]. There is a seven times greater 
risk of diabetes in obese people compared to those of 
healthy weight, with a threefold increase in risk for 
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overweight people [3].  
Obesity is thought to trigger changes to the body’s me-
tabolism. These changes cause fat tissue (adipose tis-
sue) to release fat molecules into the blood, which can 
affect insulin responsive cells and lead to reduced insu-
lin sensitivity. Both insulin secretion and insulin re-
sistance develops early in obese persons who progress 
later on to diabetes.  
Diet, nutrition and changing lifestyles are the major 
factors responsible for the increase incidence of diabe-
tes in developing as well as developed countries. De-
spite having lower overweight and obesity rates, India 
has a higher prevalence of diabetes compared to west-
ern countries suggesting that diabetes may occur at a 
much lower body mass index (BMI) in Indians compared 
with Europeans [4].  
 
Aims and Objectives:  
 
1. To establish a link between obesity and type 2 dia-
betes, 
2. To define the role of abdominal obesity in type 2 
diabetes, 
3. To correlate the dysglycemia with obesity .  
 
MATERIALS AND METHODS  
 
Study design: This was an observational study  
Ethical approval: Approval by the Institutional Ethics 
committee and informed consent from all the subjects 
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enrolled in the study was obtained. 
Study place: Outpatients from medicine department of 
Dr. Pinnamaneni Siddhartha Institute of Medical Sci-
ences and Research Foundation. 
Sampling method:  The subjects were selected by a 
systematic random sampling initially and divided into 
groups based on BMI.  
Sample size:  A total of 100 type 2 diabetes mellitus 
subjects of both sex were enrolled.   
Inclusion criteria: Subjects in the age group of 30-70 
years, obese [5] and type 2 diabetics of both sexes with 
more than one year duration of diabetes were included 
in the study.  
Exclusion criteria: Subjects having cardiovascular or 
renal diseases and pregnant women, those who were 
on drugs (other than anti diabetics) that could alter the 
blood glucose and glycosylated haemoglobin levels like 
corticosteroids, oral contraceptives, thiazides diuretics, 
ascorbic acid, quinolones, beta blockers  were excluded 
from the study.  
Methodology: 
Anthropometric measurements, detailed history and 
biochemical indices were assessed for all the selected 
individuals. History regarding age, sex, duration of dia-
betes and family history of diabetes was recorded for 
all the subjects. Measurements were taken without the 
subjects wearing shoes or heavy clothing and according 
to the revised consensus guidelines. Body Mass Index 
(BMI) was calculated using the formula, weight in kilo-
grams divided by height in meters squared (kg/m2). The 
waist circumference (WC) was measured using non-
stretchable flexible tape in horizontal position, just 
above the iliac crest, at the end of normal expiration, in 
fasting state, with the subject standing erect and look-
ing straight forward and observer sitting in front of the 
subject. The currently recommended cut-offs of BMI 
and WC were based on the revised consensus guide-
lines for India [5] Normal BMI: 18.0-22.9 kg/m2, Over-
weight: 23.0-24.9 kg/m2, Obesity: >25 kg/m2 and for 
WC are, Men: 90 cm, women: 80 cm, so grouping done 
accordingly as mentioned above.  The subject was 
asked to fast overnight for a period of minimum eight 
hours. Venous blood sample was collected from the 
antecubital vein and analyzed for fasting plasma glu-
cose (FPG) and glycosylated haemoglobin (HbA1c).  
Fasting plasma glucose was analyzed by glucose oxi-
dase method [6] and HbA1c by Latex agglutination [7] 
inhibition assay on Randox Daytona automated analyz-
er.  
Subjects were defined as having diabetes if there is 
documented evidence of diabetes or they were on oral 
hypoglycemics drugs or on insulin. Hypertension was 
diagnosed in subjects who were on antihypertensive 
medications or had a systolic BP≥140 mmHg and/or a 
diastolic BP ≥90 mmHg. 
Generalised obesity (GO) is obesity based on BMI, Ab-
dominal obesity (AO) based on waist circumference 
(WC) and combined obesity (CO) when subjects have 
both GO and AO. Based on the gender and BMI the 
subjects were divided into three groups as those with 
normal BMI- Group I, overweight- Group II and obese 
Group III.  
Statistical Analysis: Data was analyzed using SPSS soft-
ware version 16. Non-parametric statistics were used 
for continuous variables that were non-normally dis-
tributed and parametric statistics was used for continu-
ous variables that were normally distributed. Descrip-
tive statistics were be used to identify the demographic 
and clinical details of the total sample. The statistical 
analysis was done by the unpaired two tailed ‘t’ test, 
Pearson’s correlation coefficient and kruskal wallis test. 
The statistical significance was kept as a p value of 
<0.05.  
 
RESULTS  
 
A total 100 type 2 diabetes mellitus subjects were en-
rolled out of which 57(57%) were females and 43(43%) 
were male diabetics. The mean age(in years), age of 
onset of diabetes (in years), duration of diabetes (in 
years), fasting plasma glucose (FPG in mg/dl), glycated 
haemoglobin (HbA1c%), body mass index (BMI in kg/
m2 ) and waist circumference (WC in cm), systolic 
blood pressure (SBP in mm/Hg) and diastolic blood 
pressure (DBP in mm/Hg) of type 2 diabetics were 
50±9.51, 43.9±7.39, 5.78±4.58, 157±51.5, 8.2±1.64, 
27.7±5.03, 97±10.8, 129.6±15.94 and 80.2±10.44 re-
spectively. Family history of diabetes was seen in 66 
percent, hypertension in 36 percent and thyroid disor-
der in 6 percent of the total sample.   
Gender wise the percentage of the diabetics who gave 
a positive family history of diabetes, history of hyper-
tension and had thyroid disorder was more among the 
females than among the males, while smoking and al-
cohol drinking were predominantly seen in the males. A 
larger proportion of the diabetics of both sexes were 
on oral hypoglycaemic agents (OHA), from rural areas, 
had poorer glycemic control HbA1c >7%, higher BMI 
and waist circumference (WC). The most predominant 
occupation for female diabetics was housework while 
for males it was agriculture (Table 1). 
Generalised obesity (GO), Abdominal obesity (AO) and 
combined obesity (CO) were seen in 72, 80 and 63 per-
cent of the diabetic population respectively (Table 2). 
The mean age, duration of diabetes, FPG, were higher 
in male than in female diabetics while the mean levels 
of BMI and HbA1c are higher in female than male dia-
betics but were not statistically significant. Duration of 
diabetes was longer in male as compared to female 
diabetics and statistically significant. Age of onset, sys-
tolic and diastolic blood pressure were found to be only 
marginally elevated in males as compared to female 
diabetics (Table 3).  
A positive correlation was observed between the BMI 
and WC of both female and male diabetics (Figure 1) 
and (Figure 2), between BMI and HbA1c of both female 
and male diabetics (Figure 3 and Figure 4) and between 
WC and HbA1c of both female and male diabetics 
(Figure 5 and Figure 6). All the correlations showed a 
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significant p value. 
An increasing trend in WC and BMI and HbA1c is seen 
from Group I to Group III with a statistical significant 
difference. A statistical significant difference was noted 
also for age of the diabetics, and age of onset of diabe-
tes on comparison of the three groups- Group I, II and 
III (Table 4).  
 
DISCUSSION 
 
Several large randomized prospective trials have 
demonstrated that an HbA1c target of 7% or below was 
associated with significantly lower risk of diabetes-
related microvascular complications. [8,9]. 
Diabetes mellitus is rapidly reaching potentially epidemic 
proportions in India and the level of morbidity and mor-
tality due to diabetes and its potential complications are 
enormous. Diabetes imposes a large economic burden on 
individuals, family, society and on the national healthcare 
system as a whole. 
The prevalence of T2DM parallels the increasing preva-
Characteristics Females   Males 
Nos 57 (57)   43 (43) 
Family history 40 (70.2)   26 (60.5) 
Hypertension 20 (35.1)   16 (37.2) 
Thyroid disorder 6 (10.5) 0 (0) 
Alcohol 1 (1.8)   24 (55.8) 
Smoking 1 (1.8)   21 (48.8) 
Anti-diabetics  
OHA 44 (77.2)   41 (95.3) 
OHA & Insulin 13 (22.8)  2 (4.7) 
Diet  
Vegetarian 1 (1.8)  1 (2.3) 
Mixed 56 (98.2)   42 (97.7) 
Habitation  
Rural 34 (59.6)   26 (60.5) 
Urban 23 (40.4)   17 (39.5) 
Occupation  
Housework 34 (59.6)  0 (0) 
Daily Wage 15 (26.3)     7 (16.3) 
Agriculturer 7 (12.3)   12 (27.9) 
Teacher 1 (1.8)   4 (9.3) 
office/disability 0 (0)    6 (13.9) 
Shop owner 0 (0)    5 (11.6) 
driver 0 (0)   3 (7.0) 
carpenter/painter 0 (0)    6 (13.9) 
HbA1c  
<7% 18 (31.6)    15 (34.9) 
>7% 39 (68.4)   28(65.1) 
WC  
F   <80 cm 1 (1.8)    ---- 
F   >80 cm 56 (98.2)    ---- 
M  <90 cm -----   19 (44.2) 
M >90 cm -----   24 (55.8) 
BMI  
 18.0-22.9 kg/m2 3 (5.3) 11 (25.6) 
23.0-24.9 kg/ m2 12 (21) 2 (4.6) 
   >25 kg/m2  42 (73.7)  30 (69.8)  
Data presented as number of patients with percent-
ages in parentheses  
Table 1. Clinical and biochemical characteristics in 
T2DM based on gender 
Types of 
obesity 
Female 
(57) 
Males 
(n=43) 
Total (n=100) 
Generalised 
Obesity 
42(73.7) 30(69.8) 72(72) 
Abdominal 
Obesity 
56(98.2) 24(55.8) 80(80) 
Combined 
Obesity 
42(73.7) 23(53.5)) 63(63) 
Data presented as number of patients with  
percentages in parentheses 
Table 2. Characteristics of types of obesity in T2DM 
Characteristics 
Females 
(n=57) 
Males
(n=43) 
p value 
Age (yrs) 48.49±9.47 52.04±9.29  0.0643 
Age of onset (yrs) 43.63±7.23 44.23±7.67  0.6899 
Duration of DM 
(yrs) 
4.84±3.7 7.02±5.33 0.017* 
SBP(mm/Hg) 127.89±14.73 131.86±17.4  0.2202 
DBP(mm/Hg) 79.65±10.17 80.93±4.87 0.4482 
WC(cm) 98.63±10.25 94.93±11.27 0.09 
BM I(kg/m2) 28.58±5.02 26.64±4.87 0.0531 
FPG (mg%) 151.02±52.2 164.95±50.1   0.183 
HbA1c (%) 8.31±1.68 8.1±1.6 0.4528 
Data presented as  Mean ±  SD, *P<0.05  
Table 3. Clinical and biochemical characteristics in     
female and male diabetics 
Figure 1. Correlation between BMI and WC in female 
diabetics 
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lence of obesity. The increase in the incidence and 
prevalence of type 2 diabetes over the past few dec-
ades is due to obesity reaching to epidemic proportions 
[1]. Over the years an increase prevalence of obesity in 
both urban and rural India has been observed [10]. 
Obesity is one of the major risk factor for type 2 diabe-
tes, yet there has been little research focusing on this 
risk factor across India. 
Both type 2 diabetes and obesity are associated with 
insulin resistance due to β cell dysfunction resulting in 
increased release of NEFAs [11]. Another important fac-
tor that determines insulin sensitivity is body fat distribu-
tion. Insulin resistance is associated with body mass index 
at any degree of weight gain. Individuals whose fat distri-
bution is more peripheral have more insulin sensitivity 
than do individuals whose fat distribution is more central 
[12].  
The mean BMI and WC of the subjects in this study was 
27.7 kg/m2 and 97cm, indicating that on average, sub-
jects were obese. Diabetes prevalence and body mass 
index differ by ethnicity. Studies have shown that the 
mean BMI of the Asian subjects was lower compared to 
that of patients from other ethnic backgrounds and the 
risk of type 2 diabetes starts at a lower BMI for Asians 
than other ethnicities. The mean BMI of the subjects in 
other studies was 26 kg/m2 [13] and in another study BMI 
in female diabetics was 28.60 ± 4.91 and 26.47 ± 4.68 in 
male diabetics [14]. Our study is in agreement with this 
study with BMI being 28.58±5.02 and 26.64±4.87 in fe-
male and male diabetics. 
 Yousefzadeh G et al [14] observed mean BMI and WC 
were significantly more prevalent in women than men 
but in our study, though mean BMI and WC were signifi-
cantly more prevalent in women than men, it was not 
statistically significant. 
Figure 2. Correlation between BMI and WC in male 
diabetes 
Figure 3. Correlation between BMI and HbA1c in    
female diabetics 
Figure 4. Correlation between BMI and HbA1c in male 
diabetics 
Figure 5. Correlation between WC and HbA1c in female 
diabetics 
Figure 6. Correlation between WC and HbA1c in male 
diabetics 
Int. j. clin. biomed. res. 2017;3(3): 34-39. 
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In a study by Sheth et al the prevalence of central obe-
sity was found to be higher (75 %) compared to periph-
eral obesity (59.83 %) in overall study population [15]. 
Pradeepa R et al observed an increasing trend in all 
three types of obesity- generalized obesity (GO), ab-
dominal obesity (AO) and combined obesity (CO) with 
glucose intolerance. They observed GO, AO and CO in 
48.5 %, 57.9% and 44.6%   of the diabetics respectively 
[10]. Our study reports a higher prevalence of all the 
three types of obesity viz; 72%, 80% and 63% in GO, 
AO, and CO respectively.   
Anjana RM et al (2014) found males to be significantly 
more active than females [16] while Pradeepa R et al 
observed that the female gender, hypertension, diabe-
tes, higher socio-economic status, physical inactivity 
and urban residence were significantly associated with 
generalized, abdominal and combined obesity [10]. 
Our study shows a higher percentage of the female 
diabetics associated with housework and males with 
agriculture. This can also explain the higher incidence 
of obesity in female diabetics in our study. 
Good glycaemic control (HbA1c < 7%) was observed in 
approximately one-thirds of the diabetic rural and ur-
ban population in our study which is in accordance with 
the study by Unnikrishnan R [17]. 
 Another study [14]reported the mean level of HbA1c in 
total subjects as 8.56 ± 4.72% (mean 7.80%) in which 
only 31.66% of men and 26% of women had controlled 
level of HbA1c (<7%). Our study showed a lower mean 
HbA1c  of 8.2±1.64, and a higher percentage 34.9% of 
males and 31.6% of the female diabetics having an 
HbA1c <7%. 
In a study by Bhansali A et al, hypertension (both 
known and newly diagnosed) has been observed in 
approximately one-fourth of the studied population 
[18] whereas our study shows more than one-third of 
the diabetic population as hypertensive. 
Firouzi S et al reported that there were no statistically 
significant differences between men and women in 
terms of glycemic and metabolic status. However, 
women had a significantly higher mean BMI and lower 
mean waist circumference compared to men [13].   
Although our study shows higher BMI and WC in wom-
en, no statistically significant differences between men 
and women in terms of glycemic and metabolic status.  
While no correlation was found between obesity and 
HbA1c control in a study by Anari R [19] Sheth et al ob-
served significant linear association of HbA1c in T2DM 
subjects with central- and peripheral obesity [15]. Our 
study shows a significant linear correlation between BMI, 
WC and HbA1c in T2DM subjects.  
 
CONCLUSION  
 
As prevalence of both central and peripheral obesity was 
observed in more in approximately half of the male dia-
betics and three fourths of the female diabetic subjects,  
with an increasing trend of dysglycemia in obese diabetic 
subjects , obesity is significantly associated with poorer 
glycemic control overall in male and female diabetic sub-
jects. 
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